Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
LITHOBID
Generic name / active ingredient
lithium carbonate 300 mg extended release oral tablet
Dosage-form class
Lithium carbonate film-coated extended-release oral tablets. 300 mg is the labelled amount per tablet; extended-release tablets, immediate-release oral lithium products, lithium citrate oral liquid, other-market products and other lithium salts are not the same product for self-conversion, combination, alternation or substitution by name or milligrams.
Route
Oral
Record reviewed
2026-09-13

Copy from the pack in hand

Source-linked reading points

  • An extended-release tablet is not an immediate-release lithium carbonate tablet or a lithium citrate oral liquid. A shared ingredient or the word “lithium” does not establish self-conversion, substitution, combination or alternation by milligrams.
  • Diuretics, ACE inhibitors/ARBs, NSAID pain medicines, dehydration, diarrhoea, vomiting, fever, marked food/fluid changes or kidney-function changes can make lithium-related risk a priority for professional review; the site generates no pause, catch-up, spacing or dose-change instruction.
  • Marked tremor or unsteadiness, slurred speech, severe drowsiness or confusion, persistent vomiting/diarrhoea, fainting, abnormal heartbeat, breathing difficulty or inability to remain safe requires local emergency or medical support immediately with every medicine pack; do not wait for a website assessment.
  • Tablet colour, imprint, a score line or “100 tablets” can only help check exact product identity. A score line itself does not permit self-splitting, reducing or changing the product.

Reviewed presentation examples — compare every field

  • 300 mg lithium carbonate per tablet; not an individual's tablet count, schedule or adjustment planNDC 62559-280-01 / NDA 018027

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-13
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image